Minapharm Pharmaceuticals
Manufacturing · Egypt · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
2t El Bardissi St, Cairo, Cairo, EgyptPhone Number
+20 224143170Website
www.minapharm.comRevenue
$80.7 MillionStock Symbol
MIPH.CAIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Minapharm Pharmaceuticals
MINAPHARM is an Egyptian pharmaceutical company backed by more than fifty years of prominent existence in the local Egyptian pharmaceutical market. During the 50's, the first privately owned Factory in Egypt "Heliopolis Pharmaceutical Laboratories" was established. By the 60's, nationalization took place and MINAPHARM stopped its activity. During the 80's, the idea of reestablishment of MINAPHARM was revived, followed by the actual start of operation of MINAPHARM and building MINAPHARM factory in 10th of Ramadan city in 1958.Explore more
Minapharm Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Minapharm Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Minapharm Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Minapharm Pharmaceuticals has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Minapharm Pharmaceuticals
Click to see if Minapharm Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Minapharm Pharmaceuticals recently announced quarterly report
Check if Minapharm Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Minapharm Pharmaceuticals launches new products
Check out if Minapharm Pharmaceuticals is spiking on competitors!
Recommended Actions
Find VP level buyers at Minapharm Pharmaceuticals
Find 3 more new buyers
Company Profile Activity
Activity Insights
Minapharm Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Minapharm Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Minapharm Pharmaceuticals.
Minapharm Pharmaceuticals Tech Stack
A closer look at the technologies used by Minapharm Pharmaceuticals
Minapharm Pharmaceuticals News & Media
Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa
BERLIN, CAIRO and DUBAI, UAE, Nov. 30, 2022 /PRNewswire/ -- Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH, a Berlin-based pharmaceutical company, announced today the signing of an exclusive license...ProBioGen and Minapharm Pharmaceuticals incorporate MiGenTra GmbH - A Healthcare Transforming Medicines Company
BERLIN and CAIRO, May 27, 2021 /PRNewswire/ -- ProBioGen and Minapharm Pharmaceuticals announce the incorporation of ProBioGen's subsidiary "MiGenTra" with headquarters in Berlin and access to a site in Cairo, which will house its principal manufacturing plant. The formation of MiGenTra accelerates ProBioGen's 2030 growth roadmap and showcases that further growth is not limited to the ongoing capacity increase but reveals one of several significant steps in the diversification of ProBioGen's busRDIF and Minapharm agree to produce over 40 million doses of the Sputnik V vaccine in Egypt
MOSCOW, CAIRO and BERLIN, April 22, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), Egypt's Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary, ProBioGen AG, announce the agreement to produce over 40 million doses per year of the world's first registered vaccine against COVID-19, Sputnik V. The parties intend to commence technology transfer immediately. The rollout of the vaccine is expected in 3Q 2021. RDBioGaia signs exclusive agreement in Egypt
BioGaia has signed an agreement with Minapharm Pharmaceuticals for the exclusive rights to sell BioGaia Protectis drops in Egypt. The probiotic will be sold under the BioGaia brand. Launch is planned to Q4 2021. Minapharm is a leading pharmaceutical company in Egypt and the Middle East and the premier biopharmaceutical company in the region. Minapharm develops, manufactures and commercialises medicines ranging from small molecules to complex genetically engineered proteins, as well as develops a
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Minapharm Pharmaceuticals
Sign Up For FreeTo access detailed company insights
MINAPHARM is an Egyptian pharmaceutical company backed by more than fifty years of prominent existence in the local Egyptian pharmaceutical market. During the 50's, the first privately owned Factory in Egypt "Heliopolis Pharmaceutical Laboratories" was established. By the 60's, nationalization took place and MINAPHARM stopped its activity. During t... Read More
